Cross-sectional

Snail control in Niger and Tanzania

Part of gaining control studies

Countries: Niger | Tanzania
Diseases: Schistosomiasis

Gaining schistosomiasis control in Kenya, Mozambique, and Tanzania

Gaining Control: >25% Prevalence MDA strategies; and subtle morbidity of Cohort; Population genetics, and snail monitoring

Countries: Kenya | Mozambique | Tanzania

Sustaining and gaining schistosomiasis control in Niger

Sustaining / Gaining Control with Single versus Double Treatment; and Population genetics, snail monitoring

Countries: Niger

Sustaining schistosomiasis control in Cote D'Ivoire and Kenya

MDA strategies: Sustaining control at 10 – 24% prevalence

Countries: Cote d'Ivoire | Kenya

Schistosomiasis elimination in Zanzibar

(1) Is it possible to eliminate schistosomiasis as a public health problem on Unguja in three years and to interrupt transmission in five years? (2) Is it possible to control schistosomiasis throughout Pemba (prevalence <10%) in three years and to eliminate it as a public health problem in five years? (3) What are the costs, successful strategies, barriers, etc. associated with three different interventions (MDA, vector control, and behavior change)?

Countries: Tanzania
Diseases: Schistosomiasis

Analysis of MDA frequency and Brugia in Indonesia

Comparison of 2X vs. 1X per year MDA on Brugia with MDA of DEC/Alb , plus STH evaluation

Countries: Indonesia

Analysis of MDA for LF in loa endemic countries

Community MDA with 2X Alb alone for W. bancrofti in areas co-endemic for L. loa, plus STH evaluation

Countries: Congo | Dem. Rep. of Congo

Analysis of MDA frequency in Liberia and Cote D'Ivoire

Comparison of 2X vs. 1X per year MDA on W. bancrofti with MDA of IVM/Alb, plus STH evaluation (and Schistosoma in Foya only)

Countries: Liberia | Cote d'Ivoire

Analysis of MDA frequency in Indonesia and Papua New Guinea

Comparison of 2X vs. 1X per year MDA, W. bancrofti with MDA of DEC/Alb, plus STH evaluation

Pages